Health Care

Making Healthcare More Affordable with Doug Hirsch, Co-Founder & CEO, GoodRx

Jun. 14, 2021

This article was originally published on Cowen.com

Guest: Doug Hirsch, Co-Founder & CEO of GoodRx

Host: Charles Rhyee, Health Care Analyst, TD Cowen

Doug Hirsch, Co-Founder & CEO of GoodRx speaks with Charles Rhyee, Health Care Technology Analyst Charles Rhyee. They discuss the problems of access and affordability in healthcare, as well as how GoodRx’s offerings help patients find prescriptions at the lowest prices and increase patient access to care. Press play to listen to the podcast.

Doug co-founded GoodRx in 2011. The company provides access to price transparency and affordable solutions for generic and brand medications. This has saved Americans $30 billion on prescription medications since its founding. They also provide affordable and convenient medical provider consultations via telehealth. Doug has spent decades building technology that helps everyday consumers, starting as one of the first employees at Yahoo! before moving onto Facebook as VP of Product, and then founding DailyStrength.

Full transcription

Coming soon.

Disclaimer

This podcast should not be copied, distributed, published or reproduced, in whole or in part. The information contained in this recording was obtained from publicly available sources, has not been independently verified by TD Securities, may not be current, and TD Securities has no obligation to provide any updates or changes. All price references and market forecasts are as of the date of recording. The views and opinions expressed in this podcast are not necessarily those of TD Securities and may differ from the views and opinions of other departments or divisions of TD Securities and its affiliates. TD Securities is not providing any financial, economic, legal, accounting, or tax advice or recommendations in this podcast. The information contained in this podcast does not constitute investment advice or an offer to buy or sell securities or any other product and should not be relied upon to evaluate any potential transaction. Neither TD Securities nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed.

Charles Rhyee

Managing Director, Health Care - Health Care Technology Research Analyst, TD Cowen

Charles Rhyee
Managing Director, Health Care - Health Care Technology Research Analyst, TD Cowen

Biography

Charles Rhyee is a managing director and senior research analyst covering the Health Care Technology and Distribution space. Mr. Rhyee has been recognized in polls conducted by The Wall Street Journal and The Financial Times. In 2023, he ranked #3 in Institutional Investor’s 2023 All-America Survey in Health Care Technology and Distribution and was named “Best Up & Coming Analyst” in 2008 and 2009.

Prior to joining TD Cowen in February 2011, he was an executive director covering the Health Care Technology and Distribution sector for Oppenheimer & Co. Mr. Rhyee began his equity research career at Salomon Smith Barney in 1999.

He holds a BA in economics from Columbia University.